Andrew W Silagy

8PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied theatreAnaesthesiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 25, 2025
Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer.

Andrew W Silagy, Dixon T S Woon, Louise Kostos

|Aug 17, 2023
Localised non-metastatic sarcomatoid renal cell carcinoma: a 31-year externally verified study.

Kyle A Blum, Andrew W Silagy, Andrea Knezevic

|Jun 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.

Phillip M Rappold, Lynda Vuong, Josef Leibold

|Apr 27, 2022
Surgical innovation revisited: A historical narrative of the minimally invasive "Agarwal sliding-clip renorrhaphy" technique for partial nephrectomy and its application to an Australian cohort.

A W Silagy, R Young, B D Kelly

|Jul 21, 2021
Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma.

Andrew W Silagy, Ritesh R Kotecha, Stanley Weng

|Jul 01, 2021
The association between modifiable perioperative parameters and renal function after nephrectomy.

Roy Mano, Amy L Tin, Andrew W Silagy

Pageof 2

Frequent Collaborators

2 joint publications

Phillip M Rappold

2 joint publications

Ritesh R Kotecha

2 joint publications

Ari A Hakimi

2 joint publications

Roy Mano